Figure 2

Heart failure guideline-directed medical therapies at follow-up compared with baseline for very low-dose and standard dose of sacubitril/valsartan groups. Panel (A) Pattern of dose titration, comparing very low-dose and standard dose sacubitril/valsartan groups (panel A). Pane (B) Proportions of patients achieving different sacubitril/valsartan dose levels in the very low-dose and standard dose sacubitril/valsartan groups (panel B). Panel C: Dosing of other heart failure treatments in the very low-dose and standard dose sacubitril/valsartan groups. The p-value represents a comparison between very low-dose and standard dose of sacubitril/valsartan at baseline and follow-up.